1. Home
  2. ACU vs MSLE Comparison

ACU vs MSLE Comparison

Compare ACU & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acme United Corporation.

ACU

Acme United Corporation.

HOLD

Current Price

$56.13

Market Cap

160.6M

ML Signal

HOLD

Logo Satellos Bioscience Inc. Common Stock

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$10.04

Market Cap

154.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ACU
MSLE
Founded
1867
N/A
Country
United States
Canada
Employees
N/A
21
Industry
Industrial Machinery/Components
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
160.6M
154.6M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
ACU
MSLE
Price
$56.13
$10.04
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$50.00
N/A
AVG Volume (30 Days)
13.0K
100.3K
Earning Date
04-23-2026
N/A
Dividend Yield
1.56%
N/A
EPS Growth
1.63
N/A
EPS
0.24
N/A
Revenue
$196,541,816.00
N/A
Revenue This Year
$5.67
N/A
Revenue Next Year
$5.25
N/A
P/E Ratio
$224.75
N/A
Revenue Growth
1.05
N/A
52 Week Low
$35.50
$5.44
52 Week High
$55.43
$13.39

Technical Indicators

Market Signals
Indicator
ACU
MSLE
Relative Strength Index (RSI) 79.35 62.54
Support Level $39.97 $6.71
Resistance Level N/A $9.75
Average True Range (ATR) 2.14 0.81
MACD 0.76 0.04
Stochastic Oscillator 93.89 54.83

Price Performance

Historical Comparison
ACU
MSLE

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: